WallStreetZenWallStreetZen

NASDAQ: BCEL
Atreca Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for BCEL

Based on 2 analysts offering 12 month price targets for Atreca Inc.
Min Forecast
$4.00+284.62%
Avg Forecast
$9.00+765.38%
Max Forecast
$14.00+1,246.15%

Should I buy or sell BCEL stock?

Based on 2 analysts offering ratings for Atreca Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BCEL stock forecasts and price targets.

BCEL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Wedbush
Top 39%
62
BuyMaintains$4.00+284.62%2022-11-15
Stifel Nicolaus
Bottom 7%
7
Strong BuyMaintains$14.00+1,246.15%2022-03-04

1 of 1

Forecast return on equity

Is BCEL forecast to generate an efficient return?
Company
-86.45%
Industry
13.87%
Market
62.54%
BCEL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BCEL forecast to generate an efficient return on assets?
Company
-48.36%
Industry
13.22%
BCEL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BCEL earnings per share forecast

What is BCEL's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
-$2.71
Avg 2 year Forecast
-$2.28
Avg 3 year Forecast
-$2.47

BCEL revenue forecast

What is BCEL's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$25.0M
Avg 2 year Forecast
$5.0M
Avg 3 year Forecast
$12.8M

BCEL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BCEL$1.04$9.00+765.38%Strong Buy
MAIA$3.69N/AN/A
FRLN$0.62$10.00+1,512.90%Strong Buy
ALGS$0.96$6.00+525.00%Hold
CNTB$0.72$5.17+620.64%Buy

Atreca Stock Forecast FAQ

Is Atreca Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: BCEL) stock is to Strong Buy BCEL stock.

Out of 2 analysts, 1 (50%) are recommending BCEL as a Strong Buy, 1 (50%) are recommending BCEL as a Buy, 0 (0%) are recommending BCEL as a Hold, 0 (0%) are recommending BCEL as a Sell, and 0 (0%) are recommending BCEL as a Strong Sell.

If you're new to stock investing, here's how to buy Atreca stock.

What is BCEL's earnings growth forecast for 2022-2024?

(NASDAQ: BCEL) Atreca's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17%.

Atreca's earnings in 2022 is -$105,330,000.On average, 7 Wall Street analysts forecast BCEL's earnings for 2022 to be -$105,872,630, with the lowest BCEL earnings forecast at -$117,983,521, and the highest BCEL earnings forecast at -$96,105,782. On average, 7 Wall Street analysts forecast BCEL's earnings for 2023 to be -$89,073,651, with the lowest BCEL earnings forecast at -$101,965,891, and the highest BCEL earnings forecast at -$73,837,369.

In 2024, BCEL is forecast to generate -$96,496,456 in earnings, with the lowest earnings forecast at -$107,825,999 and the highest earnings forecast at -$83,994,891.

What is BCEL's revenue growth forecast for 2022-2024?

(NASDAQ: BCEL) Atreca's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 25.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.8%.

Atreca's revenue in 2022 is $0.On average, 1 Wall Street analysts forecast BCEL's revenue for 2022 to be $976,684,775, with the lowest BCEL revenue forecast at $976,684,775, and the highest BCEL revenue forecast at $976,684,775. On average, 1 Wall Street analysts forecast BCEL's revenue for 2023 to be $195,336,955, with the lowest BCEL revenue forecast at $195,336,955, and the highest BCEL revenue forecast at $195,336,955.

In 2024, BCEL is forecast to generate $500,062,605 in revenue, with the lowest revenue forecast at $500,062,605 and the highest revenue forecast at $500,062,605.

What is BCEL's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: BCEL) forecast ROA is -48.36%, which is lower than the forecast US Biotechnology industry average of 13.22%.

What is BCEL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year BCEL price target, the average BCEL price target is $9.00, with the highest BCEL stock price forecast at $14.00 and the lowest BCEL stock price forecast at $4.00.

On average, Wall Street analysts predict that Atreca's share price could reach $9.00 by Nov 15, 2023. The average Atreca stock price prediction forecasts a potential upside of 765.38% from the current BCEL share price of $1.04.

What is BCEL's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: BCEL) Atreca's current Earnings Per Share (EPS) is -$2.76. On average, analysts forecast that BCEL's EPS will be -$2.71 for 2022, with the lowest EPS forecast at -$3.02, and the highest EPS forecast at -$2.46. On average, analysts forecast that BCEL's EPS will be -$2.28 for 2023, with the lowest EPS forecast at -$2.61, and the highest EPS forecast at -$1.89. In 2024, BCEL's EPS is forecast to hit -$2.47 (min: -$2.76, max: -$2.15).

What is BCEL's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: BCEL) forecast ROE is -86.45%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.